ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Free cash flow 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.3MFY2025 · since FY2018: -$14.1M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | +94.4% |
| FY2024 | -$112.3M | +54.6% |
| FY2023 | -$247.5M | +4.1% |
| FY2022 | -$258.0M | -46.9% |
| FY2021 | -$175.6M | -54.9% |
| FY2020 | -$113.4M | -162.8% |
| FY2019 | -$43.1M | -206.2% |
| FY2018 | -$14.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice